Envestnet Portfolio Solutions’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $380K | Buy |
1,164
+297
| +34% | +$96.8K | ﹤0.01% | 1232 |
|
|
2025
Q1 | $234K | Sell |
867
-1,195
| -58% | -$323K | ﹤0.01% | 1413 |
|
|
2024
Q4 | $485K | Buy |
2,062
+880
| +74% | +$207K | ﹤0.01% | 1258 |
|
|
2024
Q3 | $325K | Buy |
1,182
+43
| +4% | +$11.8K | ﹤0.01% | 1406 |
|
|
2024
Q2 | $277K | Sell |
1,139
-270
| -19% | -$65.6K | ﹤0.01% | 1425 |
|
|
2024
Q1 | $211K | Buy |
1,409
+41
| +3% | +$6.13K | ﹤0.01% | 1545 |
|
|
2023
Q4 | $262K | Buy |
1,368
+89
| +7% | +$17K | ﹤0.01% | 1366 |
|
|
2023
Q3 | $227K | Buy |
+1,279
| New | +$227K | ﹤0.01% | 1375 |
|